![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Uncovering a healthier remedy for chronic pain
Physicians and patients who are wary of addiction to pain medication and opioids may soon...
Benefits of Pradaxa® maintained in difficult to treat patients with atrial fibrillation and symptomatic...
Published in the European Journal of Heart Failure1, results from a new sub-analysis of the...
Immune-boosting colorectal cancer drug shows promise
New data on an emerging treatment that aims to fight colorectal cancer by stimulating the...
FDA takes action to protect consumers from dangerous medicines sold by illegal online pharmacies
The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies,...
Targeted viral therapy destroys breast cancer stem cells in preclinical experiments
A promising new treatment for breast cancer being developed at Virginia Commonwealth University Massey Cancer...
FDA obtains waiver from European Commission to facilitate export for U.S. pharmaceutical manufacturers
The U.S. Food and Drug Administration announced that the U.S. is now a "listed" countrydisclaimer...
Aspirin may fight cancer by slowing DNA damage
Aspirin is known to lower risk for some cancers, and a new study led by...
MedImmune, AstraZeneca’s biologics arm, and NGM Biopharmaceuticals announce agreement to discover and develop therapies...
AstraZeneca announced that MedImmune, its global biologics research and development arm, and NGM Biopharmaceuticals, Inc....
Diabetes drug points the way to overcoming drug resistance in melanoma
Advanced metastatic melanoma is a disease that has proven difficult to eradicate. Despite the success...
Big multiple sclerosis breakthrough
A phase 1 clinical trial for the first treatment to reset the immune system of...